July 27, 2017 / 4:39 PM / 2 years ago

BRIEF-Arbutus expects to take two experimental hep B drugs into human studies by mid-2018 - CEO

July 27 (Reuters) - Arbutus Biopharma Corp

* Arbutus Biopharma expects to take two of its preclinical hep B drugs-in-development into human studies by mid-2018 - ceo Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below